Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Tumor of Cervix”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Temporarily pausedNCT07181720
What this trial is testing

CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Lung CancerAnaplastic Thyroid Carcinomas+3 more
Chongqing Precision Biotech Co., Ltd 90
Not applicableNot Yet RecruitingNCT07624123
What this trial is testing

Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women Living With HIV

Who this might be right for
Cervix CancerHIV InfectionsHPV Infection
UNC Lineberger Comprehensive Cancer Center 17,734
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Not applicableLooking for participantsNCT05640700
What this trial is testing

Vaginal Microbiome and HPV Pre-malignant and Cervical Dysplasia

Who this might be right for
Human Papilloma VirusVaginal Flora ImbalanceCancer Cervix Uterus+1 more
Hadassah Medical Organization 90
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Not applicableUnknownNCT05210348
What this trial is testing

Clinical Evaluation of Detection of High Risk HPV in Urine

Who this might be right for
Human Papillomavirus InfectionCervical CancerHuman Papilloma Virus+15 more
Peking University People's Hospital 1,000
Not applicableUnknownNCT05793749
What this trial is testing

Early Intervention to Prevent Lower Limb Lymphedema of Gynecological Malignancy

Who this might be right for
Uterine Cervical NeoplasmsEndometrial NeoplasmsLymphedema+1 more
Chongqing University Cancer Hospital 400
Not applicableActive Not RecruitingNCT04452526
What this trial is testing

I Vaccinate: Testing Multi-Level Interventions to Improve HPV Vaccination

Who this might be right for
Cervical CarcinomaHuman Papillomavirus-Related Malignant Neoplasm
Ohio State University Comprehensive Cancer Center 372
Not applicableStudy completedNCT05990270
What this trial is testing

The Effect of Education Given to Women on Cervical Cancer on Knowledge, Attitude and Belief

Who this might be right for
Cancer of CervixHPV Infection
Kahramanmaras Sutcu Imam University 102
Early research (Phase 1)Study completedNCT06894771
What this trial is testing

MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001)

Who this might be right for
Malignant Neoplasm
Merck Sharp & Dohme LLC 5
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06724263
What this trial is testing

A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors

Who this might be right for
Recurrent Platinum-resistant Epithelial Ovarian CancerTriple Negative Breast Cancer (TNBC)Cervical Cancers+4 more
Tasly Biopharmaceuticals Co., Ltd. 120
Not applicableUnknownNCT06452004
What this trial is testing

Validation of Artificial Intelligence as Decision Support System in VIA (PRESCRIP-TEC)

Who this might be right for
HPV InfectionCervix CancerCervical Dysplasia
University Medical Center Groningen 600
Not applicableStudy completedNCT02124252
What this trial is testing

Community-Driven Cervical Cancer Prevention in Western Kenya

Who this might be right for
Human Papilloma Virus InfectionCarcinoma in Situ of Uterine Cervix
Duke University 7,200
Early research (Phase 1)Study completedNCT00030498
What this trial is testing

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more
National Cancer Institute (NCI) 75
Not applicableStudy completedNCT04624568
What this trial is testing

Papilocare®: Effects on Regression of Histologically Confirmed Cervical Intraepithelial Lesions 1 and Tolerance

Who this might be right for
Squamous Intraepithelial Lesions of the CervixHuman Papilloma Virus InfectionCervix Lesion
Centre Hospitalier Régional d'Orléans 81
Testing effectiveness (Phase 2)Looking for participantsNCT07285044
What this trial is testing

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

Who this might be right for
AmyloidosisBasal Cell CarcinomaBiliary Tract Carcinoma+26 more
Mayo Clinic 27
Early research (Phase 1)Active Not RecruitingNCT03589339
What this trial is testing

NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy

Who this might be right for
RadiotherapyImmunotherapyMicrosatellite Instability-High Solid Malignant Tumour+8 more
Nanobiotix 145
Large-scale testing (Phase 3)Study completedNCT02346227
What this trial is testing

Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix

Who this might be right for
Uterine Cervical DysplasiaPapillomavirus Infections
Jean-Pierre Van geertruyden 327
Early research (Phase 1)Looking for participantsNCT06022029
What this trial is testing

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

Who this might be right for
Triple Negative Breast CancerDiffuse Large B Cell LymphomaFollicular Lymphoma+11 more
OncoNano Medicine, Inc. 168
Not applicableStudy completedNCT00897442
What this trial is testing

Collecting Tumor Samples From Patients With Gynecological Tumors

Who this might be right for
Borderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more
Gynecologic Oncology Group 275
Next Page